Mäenpää PH - Search Results

1

EB 1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells.

Hansen CM, Mäenpää PH. Hansen CM, et al. Among authors: maenpaa ph. Biochem Pharmacol. 1997 Dec 1;54(11):1173-9. doi: 10.1016/s0006-2952(97)00181-0. Biochem Pharmacol. 1997. PMID: 9416968 Review.

2

Vitamin D(3) analogs (MC 1288, KH 1060, EB 1089, GS 1558, and CB 1093): studies on their mechanism of action.

Mäenpää PH, Väisänen S, Jääskeläinen T, Ryhänen S, Rouvinen J, Duchier C, Mahonen A. Mäenpää PH, et al. Steroids. 2001 Mar-May;66(3-5):223-5. doi: 10.1016/s0039-128x(00)00152-5. Steroids. 2001. PMID: 11179729 Review.

3

Inhibition of proliferation and induction of differentiation of osteoblastic cells by a novel 1,25-dihydroxyvitamin D3 analog with an extensively modified side chain (CB1093).

Ryhänen S, Jääskeläinen T, Saarela JT, Mäenpää PH. Ryhänen S, et al. Among authors: maenpaa ph. J Cell Biochem. 1998 Sep 1;70(3):414-24. doi: 10.1002/(sici)1097-4644(19980901)70:3<414::aid-jcb14>3.0.co;2-k. J Cell Biochem. 1998. PMID: 9706878

4

A novel vitamin D analog with two double bonds in its side chain. A potent inducer of osteoblastic cell differentiation.

Mahonen A, Jääskeläinen T, Mäenpää PH. Mahonen A, et al. Among authors: maenpaa ph. Biochem Pharmacol. 1996 Apr 12;51(7):887-92. doi: 10.1016/0006-2952(95)02242-2. Biochem Pharmacol. 1996. PMID: 8651937

5

Effects of a new vitamin D analog, EB 1089, on osteoblastic cells.

Mäenpää PH, Jääskeläinen T, Mahonen A. Mäenpää PH, et al. Ann N Y Acad Sci. 1995 Jun 12;761:349-50. doi: 10.1111/j.1749-6632.1995.tb31390.x. Ann N Y Acad Sci. 1995. PMID: 7625733 No abstract available.

6

Affinity of MC 903 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.

Valaja T, Mahonen A, Pirskanen A, Mäenpää PH. Valaja T, et al. Among authors: maenpaa ph. Biochem Pharmacol. 1990 Oct 15;40(8):1827-32. doi: 10.1016/0006-2952(90)90363-p. Biochem Pharmacol. 1990. PMID: 2173591

7

Affinity of 22-oxa-1,25(OH)2D3 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.

Valaja T, Mahonen A, Pirskanen A, Mäenpää PH. Valaja T, et al. Among authors: maenpaa ph. Biochem Biophys Res Commun. 1990 Jun 15;169(2):629-35. doi: 10.1016/0006-291x(90)90377-y. Biochem Biophys Res Commun. 1990. PMID: 2162670

8

Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein.

Ryhänen S, Jääskeläinen T, Mahonen A, Mäenpää PH. Ryhänen S, et al. Among authors: maenpaa ph. Biochem Pharmacol. 2003 Aug 1;66(3):495-504. doi: 10.1016/s0006-2952(03)00283-1. Biochem Pharmacol. 2003. PMID: 12907249

9

Synthetic 20-epi analogs of calcitriol are potent inducers of target-gene activation in osteoblastic cells.

Ryhänen S, Mahonen A, Jääskeläinen T, Mäenpää PH. Ryhänen S, et al. Among authors: maenpaa ph. Eur J Biochem. 1996 May 15;238(1):97-103. doi: 10.1111/j.1432-1033.1996.0097q.x. Eur J Biochem. 1996. PMID: 8665957

10

Vitamin D3 analog screening.

Väisänen S, Ryhänen S, Mäenpää PH. Väisänen S, et al. Among authors: maenpaa ph. Methods Mol Biol. 2001;176:163-75. doi: 10.1385/1-59259-115-9:163. Methods Mol Biol. 2001. PMID: 11554321 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results